Pfizer says variant first found in South Africa could significantly reduce vaccine protection
Published
A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation.
Full Article